Market Opportunity
Ischemic Heart Failure (HF)
- Heart Failure affects 5.7 million people in the U.S. and 26 million worldwide. It is a chronic disease with 50% mortality at five years and impacts 1 in 5 adults over the age of 40.
- The total costs associated with heart failure in the U.S. is estimated to be $39 billion annually and is projected to increase to $70 billion in 2030, with half of the costs related to hospitalization.
Chronic Myocardial Ischemia (CMI)
- Patients with Chronic Myocardial Ischemia suffer from poor perceived health status and psychological distress, have significant impairment in quality of life, and represent a burden to the healthcare system due to significant use of resources.
- It is estimated that between 600,000 and 1.8 million patients suffer from refractory angina, with approximately 75,000 new cases diagnosed each year.
News
28 Oct

Cardiology Today
Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy
11 May

University of Minnesota
Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response
16 Apr

Saint Joseph Mercy
St. Joseph Mercy Ann Arbor to perform clinical trial using stem cells to treat congestive heart failure
31 Jan

03 Oct

BioWorld Med Tech
Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure
26 May

press releases
Have questions?
CALL US NOW
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
EMAIL US NOW
: info@biocardia.com
biocardia takes a new and comprehensive
approach to heart failure
By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.